Corpus Intelligence IC Memo — INSPIRE SPECIALTY HOSPITAL - MW CITY 2026-04-26 16:26 UTC
IC Memo — INSPIRE SPECIALTY HOSPITAL - MW CITY
Investment Committee Memorandum | OK | 31 beds | Grade C | EBITDA uplift $671K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

INSPIRE SPECIALTY HOSPITAL - MW CITY

CCN 372012 | nan, OK | 31 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

INSPIRE SPECIALTY HOSPITAL - MW CITY is a 31-bed suburban community hospital in nan, OK with $9.0M in net patient revenue and a -0.8% operating margin. The hospital serves a payer mix of 28.9% Medicare, 17.2% Medicaid, and 53.9% commercial.

Thesis: Turnaround. Our ML models identify $671K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -0.8% to 6.6% (+744bps).

Net Revenue HCRIS$9.0M
Current EBITDA COMPUTED$-73K
Operating Margin COMPUTED-0.8%
Occupancy HCRIS49.6%
Revenue / Bed COMPUTED$291K
Net-to-Gross HCRIS48.0%
Distress Probability ML54.7%

2. Market Context & Competitive Position

147
OK Hospitals
-8.8%
State Median Margin
86
Comparable Hospitals

OK has 147 Medicare-certified hospitals with a median operating margin of -8.8%. The target's margin of -0.8% places it above the state median. Among 86 size-comparable peers (16-62 beds), the median margin is -15.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (16-62), prioritizing same-state peers. 86 hospitals in the comp set.

HospitalStateBedsRevenueMargin
INSPIRE SPECIALTY HOSPITAL - M (Target)OK31$9.0M-0.8%
STILLWATER MEDICAL CENTEROK52$270.2M-9.9%
ST ANTHONY SHAWNEE HOSPITALOK57$169.2M-6.1%
OKLAHOMA HEART HOSPITAL SOUTHOK43$148.5M-0.6%
COMMUNITY HOSPITALOK45$143.9M21.7%
OKLAHOMA SPINE HOSPITALOK23$79.0M8.4%
JACKSON COUNTY MEMORIAL HOSPITOK49$75.5M-10.7%
TULSA SPINE HOSPITALOK38$69.5M11.6%
HILLCREST HOSPITAL CLAREMOREOK41$68.5M5.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $671K (744bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$189K+210bp18mo
Denial Rate Reduction12.0%6.5%$182K+202bp12mo
Cost to Collect4.5%2.5%$180K+200bp12mo
A/R Days Reduction5200.0%3800.0%$110K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+11bp6mo

5. EBITDA Bridge

Net Collection Rate
$189K
Denial Rate Reduction
$182K
Cost to Collect
$180K
A/R Days Reduction
$110K
Clean Claim Rate
$10K
Total EBITDA Uplift$671K
Current EBITDA$-73K
+ RCM Uplift+$671K
Pro Forma EBITDA$598K
Current Margin-0.8%
Pro Forma Margin6.6%
WC Released (1x)$346K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-112K$6.2M0.00x-100.0%
Base (11x exit)10.0x11.0x$-112K$6.8M0.00x-100.0%
Bull Case9.0x11.0x$-101K$9.0M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-101K$9.8M0.00x-100.0%
Bear Case11.0x10.0x$-123K$2.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-123K$3.2M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
HighElevated distress probabilityModel estimates 54.7% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 86 hospitals with 16-62 beds
  • Same-state prioritization (n=87)
  • Comp margins: P25=-24.4% / P50=-15.5% / P75=2.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.